Compare MYSZ & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | GCTK |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 3.4M |
| IPO Year | N/A | N/A |
| Metric | MYSZ | GCTK |
|---|---|---|
| Price | $0.85 | $3.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 276.4K | 160.6K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,512,000.00 | N/A |
| Revenue This Year | $18.06 | N/A |
| Revenue Next Year | $36.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.73 | $3.21 |
| 52 Week High | $3.04 | $133.80 |
| Indicator | MYSZ | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 38.39 |
| Support Level | $0.82 | $3.29 |
| Resistance Level | $0.88 | $4.20 |
| Average True Range (ATR) | 0.07 | 0.40 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 17.81 | 41.45 |
My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.